Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Association of DCIS Size and Margin Status With Risk of Developing Breast Cancer Post-Treatment: Multinational, Pooled Cohort Study, Renée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, et al.
Heterochronic Parabiosis Causes Dacryoadenitis In Young Lacrimal Glands, Ritu Sampige
Patterns of Co-Occurring Birth Defects In Children With Anotia and Microtia, Daryl A Scott, Christian P Schaaf, Joseph W Ray, et al.
Citrate Phosphate Dextrose Alters Coagulation Dynamics Ex Vivo, Jacob B Schriner, Atharwa Mankame, Scott D Olson, et al.
Impact of Transfused Citrate on Pathophysiology in Massive Transfusion, Bryan A Cotton
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG), Carolien P Schröder, Elise van Leeuwen-Stok, Fatima Cardoso, et al.
High-Resolution Transcriptomic and Epigenetic Profiling Identifies Novel Regulators of COPD, Raluca Tamas, Thomas Muley, Marc A Schneider, et al.
Resolution of Cisplatin-Induced Fatigue Does Not Require Endogenous Interleukin-10 in Male Mice, Kiersten Scott, Nabila Boukelmoune, Cullen Taniguchi, et al.
Resolution of Cisplatin-Induced Fatigue Does Not Require Endogenous Interleukin-10 in Male MiceB, Kiersten Scott, Nabila Boukelmoune, Cullen Taniguchi, et al.
Chronic Restraint Stress Impairs Voluntary Wheel Running but Has No Effect on Food-Motivated Behavior in Mice, Kiersten Scott, Thien Trong Phan, Nabila Boukelmoune, et al.
Cisplatin Decreases Voluntary Wheel-Running Activity but Does Not Impair Food-Motivated Behavior in Mice, Kiersten S Scott, Brandon Chelette, Chinenye Chidomere, et al.
Dexmedetomidine Alters The Inflammatory Profile of Rat Microglia In Vitro
Small Molecule RBI2 Disrupts Ribosome Biogenesis through Pre-rRNA Depletion, Catherine E Scull, Guy Twa, Yinfeng Zhang, et al.
Ambient Oxygen Levels Regulate Intestinal Dysbiosis and GVHD Severity After Allogeneic Stem Cell Transplantation, Keisuke Seike, Anders Kiledal, Hideaki Fujiwara, et al.
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project, Alexander Semaan, Vincent Bernard, Justin Wong, et al.
Common Kinase Mutations Do Not Impact Optimal Molecular Responses in Core Binding Factor Acute Myeloid Leukemia Treated With Fludarabine, Cytarabine, and G-csf Based Regimens, Jayastu Senapati, Tareq Abuasab, Fadi G Haddad, et al.
Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements, Jayastu Senapati, Elias Jabbour, Marina Konopleva, et al.
A Phase I Study of Milademetan (DS3032B) in Combination With Low Dose Cytarabine With or Without Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis, Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, et al.
A Phase I Study of Milademetan (DS3032b) in Combination With Low Dose Cytarabine With or Without Venetoclax in Acute Myeloid Leukemia: Clinical Safety, Efficacy, and Correlative Analysis, Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, et al.
Venetoclax Abrogates the Prognostic Impact of Splicing Factor Gene Mutations in Newly Diagnosed Acute Myeloid Leukemia, Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
Understanding Cardiac Senescence One Cell Type at a Time, Payel Sen and Priyatansh Gurha
From Bugs to Drugs: Bacterial 3-Iaa Enhances Efficacy of Chemotherapy in Pancreatic Cancer, Y David Seo and Jennifer A Wargo
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial, Yongwoo David Seo, Hailing Lu, Graeme Black, et al.
Bi-Allelic TTI1 Variants Cause an Autosomal-Recessive Neurodevelopmental Disorder With Microcephaly, Margaux Serey-Gaut, Marisol Cortes, Periklis Makrythanasis, et al.
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial, Davide Serrano, Sara Gandini, Parjhitham Thomas, et al.